NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Cancer Vaccine Week


Susan Hasty, Publisher
Table of Contents . . . June 15th, 2009
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Cancer Vaccine Week | Other Publications

McGill University - Common diabetes drug may 'revolutionize' cancer therapies

Cancer Vaccines - Data from St. Louis University provide new insights into cancer vaccines

Cancer Vaccines - Findings from Westmead Hospital broaden understanding of cancer vaccines

Cancer Vaccines - Reports summarize cancer vaccines research from F.X. Ding and co-authors

Cancer Vaccines - Research from J. Bornstein and colleagues has provided new data on cancer vaccines

Cancer Vaccines - Researchers from Kyushu University publish new studies and findings in the area of cancer vaccines

 Human Papillomavirus - Research from E. Fukuchi and colleagues has provided new data on human papillomavirus

Vaccines - Researchers from University of Insubria discuss findings in vaccines

Advaxis, Inc. - Advaxis Develops Innovative Approach in Cancer Mechanism Targeting

Antigenics Inc. - Antigenics Presents Positive Oncophage® Interim Survival Data at ASCO

Celldex Therapeutics, Inc. - Pfizer and Celldex Therapeutics Present Update on CDX-110 PF-04948568 Phase 2 Brain Cancer Studies at 45th Annual ASCO Meeting

Merck KGaA - Merck KGaA: Follow-Up From Stimuvax Study Provides Long-Term Safety Data In Advanced Lung Cancer Patients Receiving Treatment for Up To 8.2 Years

Tuberculosis - CEL SCI Collaborators Demonstrate Novel L.E.A.P.S. Vaccines Immunize Mice Against Tuberculosis Antigens and Suggest Potential to Treat Swine and Other Influenzas

University of Pennsylvania School of Medicine - Penn study demonstrates new way to boost immune memory


Return to Top of Page

-----------------------
Home | Free Newsletters | Products | Article Library | About Us | Contact | Privacy Policy | Search | Visit VerticalNews.com
Copyright © 2009 NewsRx		 PR Login